#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sickle cell disease Lymphatic malformation Kawasaki's disease Carcinoid tumour Gaucher's disease type III Neutropenia Alveolar proteinosis Inborn error of metabolism Hypoxic-ischaemic encephalopathy Aspergillus infection Congenital pseudarthrosis Neonatal asphyxia Intracranial germ cell tumour Still's disease Haemophilia B without inhibitors More trials…

    Learn about Rare Diseases

    Alternating hemiplegia of childhood – Basic Information Medulloblastoma recurrent – Basic Information Paroxysmal nocturnal haemoglobinuria – Life with Disease Hereditary neuropathic amyloidosis – Diagnostics Breast angiosarcoma metastatic – Basic Information Castleman’s disease – Life with Disease Alagille syndrome – Diagnostics Ewing’s sarcoma recurrent – Diagnostics Hairy cell leukaemia recurrent Primary mediastinal large B-cell lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Adenosine Dexamethasone Ph. Eur. Posenacaftor Darunavir Adrenaline Acid Tartrate Bp Finerenone Masitinib Duloxetine Xaluritamig Ravulizumab Vrdn-001 Atazanavir Ht-29-B Posaconazole Perflutren Gr0015 Goserelin Acetate Dabigatran Etexilate ATTR-01 Tozorakimab More therapies…

    Learn about Your Condition

    Agitation postoperative Embolic stroke Stargardt's disease Familial hypertriglyceridaemia Carotid artery occlusion Intervertebral disc protrusion Lip and/or oral cavity cancer Myocarditis post infection Myelofibrosis Laryngeal cancer stage III Persistent depressive disorder Angiosarcoma metastatic Diabetic autonomic neuropathy Cutaneous lupus erythematosus Procedural pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of transdermal testosterone gel to improve ovarian response in women with low ovarian reserve and androgen receptor polymorphism undergoing fertility treatment

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Infertility male
    Investigated Drugs:
    • Follitropin Alfa
    • Ganirelix
    • Testosterone
    Spain

  • Study of dornase alfa and cisplatin treatment for patients with refractory germ cell cancer

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Dornase Alfa
    • Cisplatin
    Slovakia

  • Study of PSMA PET imaging versus standard imaging to guide radiation therapy in patients with intermediate or high-risk prostate cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Gozetotide
    Germany

  • Study of Ferumoxtran-10 Enhanced MRI for Detecting Lymph Node Metastases in Patients with Esophageal Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • FERUMOXTRAN-10
    The Netherlands

  • Study of Cannabidiol compared to placebo to treat alcohol dependence in adults seeking treatment to achieve abstinence

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Alcohol abuse
    Investigated Drugs:
    • CANNABINOL
    Spain

  • Study comparing low-dose versus standard-dose epinephrine for better brain recovery in patients with out-of-hospital cardiac arrest

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Epinephrine Bitartrate
    France
Previous Page
1 … 769 770 771 772 773 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!